NICOLET ADVISORY SERVICES, LLC - ZIOPHARM ONCOLOGY INC ownership

Quarter-by-quarter ownership
NICOLET ADVISORY SERVICES, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,356
-77.3%
21,5000.0%0.00%
-100.0%
Q2 2023$10,389
-19.5%
21,5000.0%0.00%0.0%
Q1 2023$12,900
-17.4%
21,5000.0%0.00%
-50.0%
Q4 2022$15,615
-49.6%
21,5000.0%0.00%
-60.0%
Q3 2022$31,000
+3.3%
21,5000.0%0.01%
+25.0%
Q2 2022$30,000
+172.7%
21,5000.0%0.00%
+300.0%
Q1 2022$11,000
-52.2%
21,5000.0%0.00%
-66.7%
Q4 2021$23,000
-41.0%
21,5000.0%0.00%
-40.0%
Q3 2021$39,000
-31.6%
21,5000.0%0.01%
-28.6%
Q2 2021$57,000
-26.0%
21,5000.0%0.01%
-36.4%
Q1 2021$77,000
+35.1%
21,500
-4.7%
0.01%
+37.5%
Q4 2020$57,0000.0%22,5550.0%0.01%
-11.1%
Q3 2020$57,00022,5550.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 2,564,925$11,132,0008.99%
Essex Woodlands Management, Inc. 2,764,908$11,330,0005.70%
Third Security, LLC 17,815,708$77,320,0003.68%
MSD Partners, L.P. 2,750,000$11,935,0000.49%
SFMG, LLC 99,850$433,0000.15%
GM Advisory Group, LLC 12,500$54,0000.06%
Geduld E E 25,000$109,0000.05%
WESTPORT RESOURCES MANAGEMENT INC 30,500$132,0000.04%
Janney Montgomery Scott LLC 335,571$1,456,378,0000.04%
WFG Advisors, LP 48,040$208,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders